New Needle for Two-Needle Hemodialysis
Our preliminary studies have demonstrated that an innovative new design of the hemodialysis venous needle (the needle that returns the cleaned blood from the hemodialysis filter to the patient) with three jets is superior to the standard venous needle because it decreases the velocity and turbulence of the blood when compared with the standard venous needle, it is more efficient in the removal of toxins from the blood, and it is safe and effective. More importantly, our preliminary studies suggested that the new needle causes less damage to the dialysis vascular access and to circulating blood cells and less inflammation and oxidative stress. These will decrease medical complications, the high cost of care and death in dialysis patients. The current study will corroborate the finding of previous studies.
100 项与 BioMedical Enterprises, Inc. 相关的临床结果
0 项与 BioMedical Enterprises, Inc. 相关的专利(医药)
100 项与 BioMedical Enterprises, Inc. 相关的药物交易
100 项与 BioMedical Enterprises, Inc. 相关的转化医学